CMP vs EMD

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CMP

COMPUMEDIC FPO [CMP]

51MEDIUM

EMD

EMYRIAL FPO [EMD]

51MEDIUM

Score Breakdown

CMP EMD
Technical
44
47
Catalyst
51
52
Sentiment
50
50
Fundamental
90
69
Momentum
68
76
Risk Gate
47
45

Key Metrics

CMP Metric EMD
$56.9MMarket Cap$29.0M
71KAvg Volume (20d)945K
N/AShort InterestN/A
$0.45052-Week High$0.078
$0.24052-Week Low$0.021
-4.4%Daily Change+2.8%
$0.282Entry Price$0.037
+0.5%ROE-58.6%
+0.2%Profit Margin-198.5%

Active Signals

CMP Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Above-average volume (1.7x) on a red day — sellers in control
Sitting near support — this level has held before and could attract buyers again
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (1.0x)
Strong revenue growth (+32%)

EMD Signals

RSI is looking oversold — historically a spot where stocks tend to bounce
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Took a hit — down 14.0% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (11 quarters)
Moderate P/S ratio (12.7x)

Ask Scout AI to compare CMP and EMD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CMP Full Analysis → EMD Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).